Searcy Financial Services’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-79,687
Closed -$7.43M 19
2022
Q4
$7.43M Sell
79,687
-440
-0.5% -$42.5K 4.32% 10
2022
Q3
$7.64M Sell
80,127
-1,124
-1% -$111K 4.84% 9
2022
Q2
$7.53M Sell
81,251
-3,906
-5% -$381K 4.67% 9
2022
Q1
$8.62M Sell
85,157
-91,000
-52% -$9.56M 5.06% 11
2021
Q4
$18.2M Buy
176,157
+84,290
+92% +$7.79M 8.13% 7
2021
Q3
$7.8M Buy
91,867
+362
+0.4% +$30.3K 4.76% 10
2021
Q2
$7.63M Sell
91,505
-1,412
-2% -$116K 4.63% 11
2021
Q1
$6.99M Buy
92,917
+132
+0.1% +$9.62K 4.43% 14
2020
Q4
$6.34M Buy
92,785
+957
+1% +$62.2K 3.79% 15
2020
Q3
$5.36M Buy
91,828
+5,594
+6% +$348K 4.01% 14
2020
Q2
$5.6M Buy
+86,234
New +$5.43M 4.67% 11

Other funds holding CVS

Searcy Financial Services's CVS Position: Q1 2023 in Review

Searcy Financial Services sold out of CVS Health (CVS) in Q1 2023, closing a stake of 79,687 shares — an estimated $7.43M sold.

Searcy Financial Services first reported a position in CVS in Q2 2020 and held it in 11 quarters. The position peaked at $18.2M in Q4 2021. 2,268 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Searcy Financial Services reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Searcy Financial Services sold 79,687 CVS Health shares in Q1 2023, an estimated $7.43M.
  • Searcy Financial Services first reported a position in CVS Health in Q2 2020 and held it in 11 quarters.
  • Searcy Financial Services's CVS Health position peaked at $18.2M in Q4 2021.
  • 2,268 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Searcy Financial Services's 13F filing for Q1 2023, filed 14 Apr 2023.